Europe Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Fusion Biopsy Market would witness market growth of 11.1% CAGR during the forecast period (2020-2026).
Diagnostics centers are anticipated to grow at a substantial rate in the coming years. It reduces wait times, developing reimbursement paradigm, and cost efficiency are some of the factors that are likely to drive the growth of the fusion biopsy market. The targeted MR/Ultrasound biopsy system is an evolving technology, the higher cost is the main barrier for their implementation in diagnostic centers. Though, it is perceived that when two diagnostic centers become partners and purchase and MR/Ultrasound fusion biopsy system, intending its quick ROI and also increasing demand for fusion biopsy.
Transperineal fusion biopsy is an evolving trend and is anticipated to show the fastest growth in the foreseeable period of time. It has a lower risk of infection and minimal rectal bleeding as compared to the traditional approach is likely to have a positive driver towards the segment growth. Furthermore, the transperineal approach is effective and more efficient in assessing the ventral areas of the prostate that are usually not identified with transrectal fusion biopsy. The market players like and Biopsee and Koelis offers accessories of both transrectal and transperineal fusion biopsy system and they are giving urologist more flexibility to facilitate personalized patient care.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
Diagnostics centers are anticipated to grow at a substantial rate in the coming years. It reduces wait times, developing reimbursement paradigm, and cost efficiency are some of the factors that are likely to drive the growth of the fusion biopsy market. The targeted MR/Ultrasound biopsy system is an evolving technology, the higher cost is the main barrier for their implementation in diagnostic centers. Though, it is perceived that when two diagnostic centers become partners and purchase and MR/Ultrasound fusion biopsy system, intending its quick ROI and also increasing demand for fusion biopsy.
Transperineal fusion biopsy is an evolving trend and is anticipated to show the fastest growth in the foreseeable period of time. It has a lower risk of infection and minimal rectal bleeding as compared to the traditional approach is likely to have a positive driver towards the segment growth. Furthermore, the transperineal approach is effective and more efficient in assessing the ventral areas of the prostate that are usually not identified with transrectal fusion biopsy. The market players like and Biopsee and Koelis offers accessories of both transrectal and transperineal fusion biopsy system and they are giving urologist more flexibility to facilitate personalized patient care.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
- Transperineal
- Transrectal
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Fusion Biopsy Market, by End Use
1.4.2 Europe Fusion Biopsy Market, by Route
1.4.3 Europe Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. EUROPE FUSION BIOPSY MARKET BY END USES
4.1 Europe Diagnostic centers Market by Country
4.2 Europe Hospitals Market by Country
4.3 Europe Ambulatory care centers Market by Country
CHAPTER 5. EUROPE FUSION BIOPSY MARKET BY ROUTE
5.1 Europe Transperineal Market by Country
5.2 Europe Transrectal Market by Country
CHAPTER 6. EUROPE FUSION BIOPSY MARKET BY COUNTRY
6.1 Germany Fusion Biopsy Market
6.1.1 Germany Fusion Biopsy Market by End Uses
6.1.2 Germany Fusion Biopsy Market by Route
6.2 UK Fusion Biopsy Market
6.2.1 UK Fusion Biopsy Market by End Uses
6.2.2 UK Fusion Biopsy Market by Route
6.3 France Fusion Biopsy Market
6.3.1 France Fusion Biopsy Market by End Uses
6.3.2 France Fusion Biopsy Market by Route
6.4 Russia Fusion Biopsy Market
6.4.1 Russia Fusion Biopsy Market by End Uses
6.4.2 Russia Fusion Biopsy Market by Route
6.5 Spain Fusion Biopsy Market
6.5.1 Spain Fusion Biopsy Market by End Uses
6.5.2 Spain Fusion Biopsy Market by Route
6.6 Italy Fusion Biopsy Market
6.6.1 Italy Fusion Biopsy Market by End Uses
6.6.2 Italy Fusion Biopsy Market by Route
6.7 Rest of Europe Fusion Biopsy Market
6.7.1 Rest of Europe Fusion Biopsy Market by End Uses
6.7.2 Rest of Europe Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Fusion Biopsy Market, by End Use
1.4.2 Europe Fusion Biopsy Market, by Route
1.4.3 Europe Fusion Biopsy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. EUROPE FUSION BIOPSY MARKET BY END USES
4.1 Europe Diagnostic centers Market by Country
4.2 Europe Hospitals Market by Country
4.3 Europe Ambulatory care centers Market by Country
CHAPTER 5. EUROPE FUSION BIOPSY MARKET BY ROUTE
5.1 Europe Transperineal Market by Country
5.2 Europe Transrectal Market by Country
CHAPTER 6. EUROPE FUSION BIOPSY MARKET BY COUNTRY
6.1 Germany Fusion Biopsy Market
6.1.1 Germany Fusion Biopsy Market by End Uses
6.1.2 Germany Fusion Biopsy Market by Route
6.2 UK Fusion Biopsy Market
6.2.1 UK Fusion Biopsy Market by End Uses
6.2.2 UK Fusion Biopsy Market by Route
6.3 France Fusion Biopsy Market
6.3.1 France Fusion Biopsy Market by End Uses
6.3.2 France Fusion Biopsy Market by Route
6.4 Russia Fusion Biopsy Market
6.4.1 Russia Fusion Biopsy Market by End Uses
6.4.2 Russia Fusion Biopsy Market by Route
6.5 Spain Fusion Biopsy Market
6.5.1 Spain Fusion Biopsy Market by End Uses
6.5.2 Spain Fusion Biopsy Market by Route
6.6 Italy Fusion Biopsy Market
6.6.1 Italy Fusion Biopsy Market by End Uses
6.6.2 Italy Fusion Biopsy Market by Route
6.7 Rest of Europe Fusion Biopsy Market
6.7.1 Rest of Europe Fusion Biopsy Market by End Uses
6.7.2 Rest of Europe Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 GERMANY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 GERMANY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 GERMANY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 GERMANY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 UK FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 UK FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 UK FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 UK FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 UK FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 UK FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 FRANCE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 FRANCE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 FRANCE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 FRANCE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 FRANCE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 FRANCE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 RUSSIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 RUSSIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SPAIN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SPAIN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SPAIN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SPAIN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 ITALY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 ITALY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 ITALY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 ITALY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 ITALY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 ITALY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
TABLE 1 EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 4 EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 5 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 GERMANY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 GERMANY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 GERMANY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 22 GERMANY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 23 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 24 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 25 UK FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 26 UK FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 27 UK FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 28 UK FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 29 UK FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 UK FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 FRANCE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 32 FRANCE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 33 FRANCE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 34 FRANCE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 35 FRANCE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 36 FRANCE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 37 RUSSIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 RUSSIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 SPAIN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 SPAIN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 SPAIN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 46 SPAIN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 47 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 ITALY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 ITALY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 ITALY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 52 ITALY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 53 ITALY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 ITALY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 62 KEY INFORMATION – HITACHI, LTD.
TABLE 63 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 64 KEY INFORMATION – ESAOTE SPA
TABLE 65 KEY INFORMATION – EIGEN
TABLE 66 KEY INFORMATION – KOELIS, INC.
TABLE 67 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 68 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
